Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients

被引：0
|
作者：
Ragne K. Farmen
Oddmund Nordgård
Bjørnar Gilje
Fuad V. Shammas
Jan T. Kvaløy
Satu Oltedal
Reino Heikkilä
机构：
[1] Stavanger University Hospital,Department of Hematology and Oncology
[2] University of Stavanger,Department of Mathematics and Natural Science
[3] Stavanger University Hospital,Division of Research and Human Resources
[4] Gena AS,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 108卷
关键词：
Breast cancer; Bone marrow; Micrometastases; Real-time RT-PCR; Cytokeratin 19; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 258
页数：7
相关论文
共 50 条
  • [41] SIGNIFICANCE OF GENE AMPLIFICATIONS ON RELAPSE-FREE SURVIVAL (RFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER
    Todorovic-Rakovic, Natasa
    Neskovic-Konstantinovic, Zora
    Nikolic-Vukosavljevic, Dragica
    BREAST, 2013, 22 : S59 - S60
  • [42] GETTING FREE OF BREAST-CANCER - AN 8-YEAR PERSPECTIVE OF THE RELAPSE-FREE PATIENTS
    HALTTUNEN, A
    HIETANEN, P
    JALLINOJA, P
    LONNQVIST, J
    ACTA ONCOLOGICA, 1992, 31 (03) : 307 - 310
  • [43] Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer
    Ricciardelli, C
    Brooks, JH
    Suwiwat, S
    Sakko, AJ
    Mayne, K
    Raymond, WA
    Seshadri, R
    LeBaron, RG
    Horsfall, DJ
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 1054 - 1060
  • [44] Is serum albumin an independent predictor of survival in patients with breast cancer?
    Lis, CG
    Grutsch, JF
    Vashi, PG
    Lammersfeld, CA
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2003, 27 (01) : 10 - 15
  • [45] Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF
    Sanchez, B. C.
    Sundqvist, M.
    Fohlin, H.
    Spyratos, F.
    Nordenskjold, B.
    Stal, O.
    Linderholm, B. K.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) : 1580 - 1587
  • [46] Effect of xenon anaesthesia on relapse-free survival in treatment of breast cancer: relation with immune status
    Avdeev, S.
    Stakheeva, M.
    Odyshev, V
    Faltin, V
    Slonimskay, E.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 11 - 11
  • [47] COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS
    Hofmann, Guenter
    Langsenlehner, Tanja
    Moazedi-Fuerst, Florentine
    Gerger, Armin
    Kielhauser, Sonja
    Absenger, Gudrun
    Szkandera, Joanna
    Samonigg, Hellmut
    Krippl, Peter
    Renner, Wilfried
    ANNALS OF ONCOLOGY, 2012, 23 : 86 - 87
  • [48] Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA
    Ikeda, N
    Miyoshi, Y
    Motomura, K
    Inaji, H
    Koyama, H
    Noguchi, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (09): : 918 - 924
  • [49] Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection
    Daskalakis, M.
    Mavroudis, D.
    Sanidas, E.
    Apostolaki, S.
    Askoxylakis, I.
    de Bree, E.
    Georgoulias, V.
    Melissas, J.
    EJSO, 2011, 37 (05): : 404 - 410
  • [50] PROGESTERONE-RECEPTOR ACTIVITY AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH PRIMARY BREAST-CANCER - THE ROLE OF ADJUVANT CHEMOTHERAPY
    RAEMAEKERS, JMM
    BEEX, LVAM
    PIETERS, GFFM
    SMALS, AGH
    BENRAAD, TJ
    KLOPPENBORG, PWC
    WOBBES, T
    VANDAAL, W
    HOLLAND, R
    HENDRIKS, J
    WAGENER, D
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 9 (03) : 191 - 199
12345